The CSB repair factor is overexpressed in cancer cells, increases apoptotic resistance, and promotes tumor growth

DNA Repair

Volumn 12, Issue 4, 2013, Pages 293-299

  Caputo, Manuela ^a   Frontini, Mattia ^b   Velez Cruz, Renier ^c   Nicolai, Serena ^a   Prantera, Giorgio ^a   Proietti De Santis, Luca ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Cancer cells; Cockayne Syndrome group B protein; Oncogene

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN; PROTEIN COCKAYNE SYNDROME GROUP B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR RESISTANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA HELICASES; DNA REPAIR ENZYMES; GENE EXPRESSION; HELA CELLS; HUMANS; MCF-7 CELLS; NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84875002376     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.01.008     Document Type: Article

References (20)

1. Chao M.P., Majeti R., Weismann I.L. Programmed cell removal: a new obstacle in the road to developing cancer. Nat. Rev. Cancer 2012, 12:58-67.
2. Matson S.W., Bean D.W., George J.W. DNA helicases: enzymes with essential roles in all aspects of DNA metabolism. Bioessays 1994, 16:13-22.
3. Selby C.P., Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:11205-11209.
4. Citterio E., Van Den Boom V., Schnitzler G., Kanaar R., Bonte E., Kingston R.E., Hoeijmakers J.H., Vermeulen W. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor. Mol. Cell. Biol. 2000, 20:7643-7653.
5. Beerens N., Hoeijmakers J.H., Kanaar R., Vermeulen W., Wyman C. The CSB protein actively wraps DNA. J. Biol. Chem. 2005, 280:4722-4729.
6. Weidenheim K.M., Dickson D.W., Rapin I. Neuropathology of Cockayne syndrome: evidence for impaired development, premature aging, and neurodegeneration. Mech. Ageing Dev. 2009, 130:619-636.
7. Natale V. A comprehensive description of the severity groups in Cockayne syndrome. Am. J. Med. Genet. 2011, 155A:1081-1095.
8. Laine J.P., Egly J.M. When transcription and repair meet: a complex system. Trends Genet. 2006, 22:430-436.
9. Bradsher J., Auriol J., Proietti de Santis L., Iben S., Vonesch J.L., Grummt I., Egly J.M. CSB is a component of RNA pol I transcription. Mol. Cell 2002, 10:819-829.
10. Yuan X., Feng W., Imhof A., Grummt I., Zhou Y. Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a. Mol. Cell 2007, 27:585-595.
11. Frontini M., Proietti-De-Santis L. Cockayne syndrome B protein (CSB): linking p53, HIF-1 and p300 to robustness, lifespan, cancer and cell fate decisions. Cell Cycle 2009, 8:693-696.
12. Filippi S., Latini P., Frontini M., Palitti F., Egly J.M., Proietti-De-Santis L. CSB protein is (a direct target of HIF-1 and) a critical mediator of the hypoxic response. EMBO J. 2008, 27:2545-2556.
13. Latini P., Frontini M., Caputo M., Gregan J., Cipak L., Filippi S., Kumar V., Vélez-Cruz R., Stefanini M., Proietti-De-Santis L. CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination. Cell Cycle 2011, 10:3719-3730.
14. Balajee A.S., Proietti-De-Santis L., Brosh R.M., Selzer R., Bohr V.A. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis. Oncogene 2000, 19:477-489.
15. Newman J.C., Bailey A.D., Fan H.Y., Pavelitz T., Weiner A.M. An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLOS Genet. 2008, 4(3):e1000031.
16. Lowe S.W., Cepero E., Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315.
17. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38-47.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:647-674.
19. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 6:393-410.
20. Stubbert L.J., Smith J.M., McKay B.C. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin. BMC Cancer 2010, 10:207.